COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,798 Articles (22,527 medRxiv, 8,271 bioRxiv)

Most recent first Previous |  Page 2464: Articles 24631-24640  | Next

Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiringmechanical ventilation.
Baker, S. A., Kowk, S., Berry, G. J., Montine, T. J.
10.1101/2020.07.05.20140467 — Posted: 2020-07-07 Discussion: Onsite
SARS-CoV-2 contributes to altering the post-transcriptional regulatory networks across human tissues by sponging RNA binding proteins and micro-RNAs
Srivastava, R., Daulatabad, S. V., Srivastava, M., Janga, S. C.
10.1101/2020.07.06.190348 — Posted: 2020-07-06 Discussion: Onsite
Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity
Graudenzi, A., Maspero, D., Angaroni, F., Piazza, R., Ramazzotti, D.
10.1101/2020.07.06.189944 — Posted: 2020-07-06
Gene Expression Network Analysis Provides Potential Targets Against SARS-CoV-2
Hernandez Cordero, A. I., Li, X., Yang, C. X., Milne, S., Bosse, Y. I., Joubert, P., Timens, W., Berge, M. v. d., Nickle, D., Hao, K., Sin, D. D.
10.1101/2020.07.06.182634 — Posted: 2020-07-06
Comparison of three TaqMan Real-Time Reverse Transcription-PCR assays in detecting SARS-CoV-2
Xiao, Y., Li, Z., Wang, X., Wang, Y., Wang, Y., Wang, G., Ren, L., Li, J.
10.1101/2020.07.06.189860 — Posted: 2020-07-06
Renal carcinoma is associated with increased risk of coronavirus infections
Tripathi, S. C., Deshmukh, V., Creighton, C. J., Patil, A.
10.1101/2020.07.02.184663 — Posted: 2020-07-06
Identification of potent and safe antiviral therapeutic candidates against SARS-CoV-2
Xiao, X., Wang, C., Chang, D., Wang, Y., Dong, X., Jiao, T., Zhao, Z., Ren, L., Dela Cruz, C. S., Sharma, L., Lei, X., Wang, J.
10.1101/2020.07.06.188953 — Posted: 2020-07-06 Discussion: Onsite
Animal Model Prescreening: Pre-exposure to SARS-CoV-2 impacts responses in the NHP model
Ricks, K. M., Herbert, A. S., Koehler, J. W., Kuehnert, P. A., Clements, T. L., Shoemaker, C. J., Kuehne, A. I., O'Brien, C. M., Coyne, S. R., Delp, K. L., Akers, K. S., Dye, J. M., Hooper, J. W., Smith, J. M., Kugelman, J. R., Beitzel, B. F., Gibson, K. M., Johnston, S. C., Minogue, T. D.
10.1101/2020.07.06.189803 — Posted: 2020-07-06
Conserved Genomic Terminals of SARS-CoV-2 as Co-evolving Functional Elements and Potential Therapeutic Targets
Chan, A. P., Choi, Y., Schork, N. J.
10.1101/2020.07.06.190207 — Posted: 2020-07-06
Discovery of Drug-like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3
Virdi, R. S., Bavisotto, R. V., Hopper, N. C., Frick, D.
10.1101/2020.07.06.190413 — Posted: 2020-07-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).